BeiGene is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents, with administrative offices in Basel; Beijing; and Cambridge, U.S. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter) and Facebook at @BeiGeneGlobal. See our community guidelines: bit.ly/39o3O6j
View Top Employees from BeiGeneWebsite | http://www.beigene.com |
Ticker | BGNE |
Revenue | $877 million |
Funding | $4.8 billion |
Employees | 3,888 (3,192 on RocketReach) |
Founded | 2010 |
Address | 55 Cambridge Parkway Suite 700W, Cambridge, Massachusetts 02142, US |
Phone | +86 10 5895 8000 |
Technologies |
JavaScript,
HTML,
PHP
+58 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
Keywords | Innovative Drug Development |
Competitors | Ablynx, Adaptimmune, Clovis Oncology, Exelixis, Seagen |
SIC | SIC Code 729 Companies, SIC Code 72 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54199 Companies, NAICS Code 54 Companies, NAICS Code 541990 Companies, NAICS Code 5419 Companies |
Looking for a particular BeiGene employee's phone or email?
The BeiGene annual revenue was $877 million in 2024.
Mehrdad Mobasher is the Chief Medical Officer, Hematology of BeiGene.
3,192 people are employed at BeiGene.
BeiGene is based in Cambridge, Massachusetts.
The NAICS codes for BeiGene are [541, 54199, 54, 541990, 5419].
The SIC codes for BeiGene are [729, 72].